Guy's & St Thomas' Education & Events

Conference director

Dr Joerg Steier | Conference Director
Joerg is Consultant Physician and Reader in Respiratory Medicine and Sleep at Guy‘s and St Thomas’ and King’s College London. Joerg has published >90 peer-reviewed manuscript and book chapters on the physiology of sleep-disordered breathing and the respiratory muscles.

His current research focus is focused on novel treatment options for sleep apnoea using transcutaneous electrical stimulation, and patient based symptoms and their association with neural respiratory drive. Besides Joerg’s scientific publications, he has edited a book about lung function testing and he supports research in public health for the sleep apnoea awareness campaign of the British Lung Foundation, he is medical advisor of a sleep apnoea charity (Hope2Sleep).

Dr Steier will be joined by an international faculty of sleep experts.

Faculty (confirmed)

Alexander Nesbitt, Consultant Neurologist, Guy’s & St Thomas’ NHS Foundation Trust, London, UK

Andrea de Vito, Ear, Nose and Throat Consultant, University of Bologna, Italy

Anita Simonds, Professor of Respiratory and Sleep Medicine, National Heart and Lung Institute, Imperial College London; Chair European School of Respiratory Medicine / Education section European Respiratory Society

Bhik Kotecha, Ear, Nose and Throat Consultant, Royal National Throat, Nose and Ear Hospital; Professor at University College London; Past President Sleep Medicine Section at the Royal Society of Medicine

Brian Kent, Consultant Physician, Guy’s & St Thomas’ NHS Foundation Trust, London, UK

Christopher Turnbull, Clinical Research Fellow in Respiratory and Sleep Medicine, University of Oxford

Dieter Riemann, Professor of Clinical Psychophysiology at the Department of Psychiatry and Psychotherapy, Freiburg University Medical Centre, Germany; Treasurer ESRS; Founder European Insomnia Network (EIN)

Derjk-Jan Dijk, Professor of Sleep and Physiology and Director of the Surrey Sleep Research Centre, named Associate Dean (research) for the Faculty of Health and Medical Sciences

Esther Schwarz, Consultant Physician, University of Zuerich, Switzerland

Ferran Barbe, Professor of Respiratory Medicine, Lleida, Spain

Geert Mayer, Associate Professor in Neurology Philipps University in Marburg, Germany; Director of the Hephata Klinik in Schwalmstadt-Treysa, Germany; President of the European Narcolepsy Network (EU-NN) of the ESRS

Georgios Kaltsakas, Consultant Physician, Guy’s & St Thomas’ NHS Foundation Trust, London, UK

Guy Leschziner, Consultant Neurologist, Guy’s & St Thomas’ NHS Foundation Trust, London, UK; Senior Lecturer, King’s College London

Hugh Selsick, Consultant Physician, Guy’s & St Thomas’ NHS Foundation Trust, London, UK

Ivana Rosenzweig, Consultant Neuropsychiatrist and Wellcome Senior Clinical Scientist Fellow, King’s College London, UK

Juliane Winkelmann, Professor of Neurology, Director Helmholtz Zentrum Munich, Germany; Institute of Neurogenetics

Kirstie Anderson, Consultant Neurologist The Newcastle upon Tyne Hospitals NHS Foundation Trust; Senior Lecturer Newcastle University

Malcolm Kohler, Professor of Respiratory Medicine, University of Zuerich, CH

Martino Pengo, Consultant Physician, Director Sleep and Hypertension Unit, University of Padua, Italy

Mary Morrell, Professor of Sleep & Respiratory Physiology, Imperial College London

Matthew Walker, Professor of Neurology at the Institute of Neurology, UCL and Consultant Neurologist at the National Hospital for Neurology and Neurosurgery

Dr Michael Farquhar, Consultant, Paediatric Sleep Medicine

Michelle Ramsay, Consultant Physician, Guy’s & St Thomas’ NHS Foundation Trust, London, UK

Nadia Gildeh, Clinical Research Fellow, King’s College London; Physician, Guy’s & St Thomas’ NHS Foundation Trust

Nicholas Hart, Professor in Critical Care and Respiratory Medicine, King’s College London; Clinical and Academic Lead Lane Fox Unit, Guy’s & St Thomas’ NHS Foundation Trust; Editor-in-Chief ‘Thorax’

Panagis Drakatos, Consultant Physician, Guy’s & St Thomas’ NHS Foundation Trust, London, UK

Patrick Murphy, Consultant Physician, Guy’s & St Thomas’ NHS Foundation Trust, London, UK; Senior Lecturer, King’s College London

Dr Victoria Revell, Senior Project Manager, University of Surrey

Renata Riha, Consultant in Sleep and Respiratory Medicine, Royal Infirmary of Edinburgh; Honorary Reader, University of Edinburgh

Rexford Muza, Consultant Physician, Guy’s & St Thomas’ NHS Foundation Trust, London, UK

Simon D Kyle, PhD, Sleep and Circadian Neuroscience Institute (SCNi), Nuffield Department of Clinical Neurosciences, Sir William Dunn School of Pathology, University of Oxford

Sophie West, Consultant Physician and Senior Lecturer, University of Newcastle

Tim Quinnell, Consultant Physician in Respiratory and Sleep Medicine, Papworth Hospital NHS Foundation Trust; University of Cambridge

Wolfgang Oertel, Professor of Neurology, Hertie Senior Research Professor, Phillips University of Marburg, Germany; Vice President of the German Neurological Society; President International RBD Study Group

Download the final agenda >>

Book your place >>

The Journal of Thoracic Disease is the exclusive publisher of the conference proceedings. Find out more here

Course fees

£195 for Consultants and General Practitioners
£150 for AHP’s and Trainee Doctors

Book your place >>

Accommodation

Delegates attending events run by Guy’s and St Thomas’ NHS Foundation Trust are eligible for reduced rates at a selection of nearby hotels.

Below is a list of hotels for which reduced rates are currently available:

• Park Plaza County Hall and Park Plaza Riverbank hotels (near St Thomas’ Hospital)
• Hilton Tower Bridge Hotel (near Guy’s Hospital)
• DoubleTree by Hilton Hotel London – Westminster (near St Thomas’ Hospital)

Currently there is a 33% discount saving for public sector / NHS staff at The Hilton

Contact us

If you have any queries, please contact the Events Team:

Email: [email protected]
Telephone: + 44 (0)207 188 1622

Internships

We offer a range of Internships for clinicians and AHP’s, ranging from one week to six weeks in duration, providing a unique opportunity to gain practical clinical experience in a ward environment. We work with you to tailor the programme to meet your specific needs and interests.

For further information and costs please contact:

Guy’s and St Thomas’ Events Team
Email: [email protected]
Telephone: +44 (0) 207 188 1622

Visiting the sleep centre

If you are interested in visiting the Sleep Disorders Centre at Guy’s & St Thomas’ NHS Foundation Trust, London, this can be individually arranged upon request.

Abstracts – poster competition

Publication in the Conference Proceedings
(Journal of Thoracic Disease)
“Best Abstract”

Please note we are no longer accepting submissions for this competition

The poster session forms a key part of the learning and networking opportunities of the conference and will be facilitated by experienced senior Consultants in the Osler Room at the Royal College of Physicians.

Posters should focus on interesting aspects of Sleep Medicine.

Process:

1. Please submit a text abstract (word document) via email to [email protected] by the end of business on 15th September 2017 (5pm, GMT)
2. You will be informed of the outcome by 6th October 2017 (acceptance/rejection)
3. If accepted, you will need to register for the conference and be available for the poster discussion during the indicated period between the lectures. Two facilitators from the steering committee will come to assess your poster during this period.

Notification of acceptance: 6 October 2017

Best abstract:
The best abstract will be awarded a bursary to attend the conference (to be decided by the steering committee during the review process in September and October).

Publication of abstracts:
Accepted abstracts will be printed in a dedicated conference issue of the Journal of Thoracic Disease the official publisher of the conference proceedings.

Guidelines – abstract submission
All abstract files should be sent by the above deadline to the following email (entitled “POSTER CUS2018, NAME_PRESENTER”: [email protected]

The files should be submitted as standard word document containing the following information:

(i) Title, limited to 150 letters
(ii) Full names of all authors
(iii) Affiliations of all authors
(iv) Correspondence address, including email contact
(v) Text body of abstract (structured: background, methods, results, conclusion), limited to 250 words

A. The reviewers will judge the abstracts and posters according to the scientific or clinical value, relevance to conference, suitability of methods to aims, conclusions, objectivity of statements, description of methods used, ethics, originality of work and overall impression.

B. Accepted abstracts will be displayed during the poster presentation session at the conference

C. The submission of an abstract constitutes a formal commitment by the corresponding author to display the poster at the conference. We therefore recommend that the submitting author of the poster registers for the Conference simultaneously with their abstract submission.

Guidelines – posters printing

A. For standardisation, all posters should be printed as a PDF presented as A0 landscape and should include:

(i) Heading: include the title, authors and affiliations
(ii) If the poster has been previously published, the author should indicate the date and publication
(iii) When presenting data and health information (including photos) all presenters must have informed consent that conforms with data protection guidelines

B. Posters not adhering to these guidelines will be rejected. The Steering Committee will take the final decision about acceptance of a poster.

C. Upon acceptance posters must be printed by the author according to the above specifications. The posters will be on display on the day of the conference (9am-5pm), and the authors must bring their posters with them on the day.

Please note:
In order to present a poster or an abstract at the conference you need to be registered as a paid delegate. Successful entrants will be charged the ‘AHP and Trainee Doctors’ rate for conference registration.

Please note the deadline for this competition has now passed and we are no longer accepting submissions

Headline sponsor

Löwenstein Medical UK Ltd. is a UK subsidiary of Löwenstein Group and represents Löwenstein Medical products. Löwenstein Medical UK offer a full range of anaesthesia workstations, neonatal ventilators, ICU-ventilators and sleep diagnostics and therapy devices, including high quality masks for the UK market.

Löwenstein Medical GmbH & Co. KG, Germany is specialised in development, production and sales of medical devices and systems. For over 30 years of company history, Löwenstein Medical have made an important contribution to patient care. In neonatal care, intensive care ventilation and anaesthetics the company develops and manufactures its own innovative products which are used worldwide. With its intensive research and development work, Löwenstein Medical always succeed in producing new products for the market, hence making a significant contribution to medical progress. Building on a first-class workforce, a well-established sales infrastructure and a company strategy which constantly aims to benefit the user, Löwenstein Medical will continue to produce and sell high-quality state of the art medical devices and systems, with the main focus being on patient care.

With more than 1800 employees and 150 branches throughout Germany, Löwenstein Medical ensure high quality products.

www.loewensteinmedical.co.uk

Contact details:
Löwenstein Medical UK Ltd.
1 E-Centre
Easthampstead Road.,
Bracknell
RG12 1NF
Telephone: +44 (0) 1344 830023

SomnoMed® – The Leader in COAT™ (Continuous Open Airway Therapy)

SomnoMed provides treatment solutions for Sleep-related Breathing Disorders such mild and severe obstructive sleep apnea. SomnoMed was commercialized on the basis of extensive clinical research. Supporting independent clinical research, continuous innovation and instituting medical manufacturing standards has resulted in SomnoDent® becoming the state-of-the-art and clinically proven medical oral appliance therapy for OSA. More than 300,000 patients around the world have been treated with SomnoDent® oral device therapy. Worn during sleep and fitted by a dental sleep specialist, the SomnoDent® line of oral appliances are customized to offer superior comfort and quality to patient.

SomnoMed keep the patient at the centre of our focus and know that successful treatment is much more than just the device. With our history of innovation, commitment to connecting physicians and dentists, SomnoMed provides patients with the products and services they need to return to enjoying their lives.

www.somnomed.com/uk

Contact Sales Manager Katie Simpson

Email [email protected] mob 07779736149

Lincoln Medical is a UK based pharmaceutical company founded in June 2000, dedicated to the development, manufacturing, and supply of prescription-only medication throughout the world.

A subsidiary of Paris – based Bioprojet Pharma Sarl, Lincoln Medical are the Marketing Authorisation Holders for the adrenaline (epinephrine) auto-injector Anapen® used by patients at risk of anaphylaxis, the severe end of an allergic reaction. Lincoln Medical are also distributors Wakix® (pitolisant), an H3 receptor antagonist for the treatment of narcolepsy with or without cataplexy.

Lincoln Medical Ltd, a Bioprojet PHARMA Group Company Unit B Stanley Court, Glenmore Business Park, Telford Road,

Salisbury, Wiltshire, SP2 7GH

Tel: +44 (0) 1722 742900

ResMed changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing, chronic obstructive pulmonary disease, and other chronic diseases. We develop innovative products and solutions to improve the health and quality of life of those who suffer from these conditions, and we work to raise awareness of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit www.resmed.com

https://www.ucbpharma.co.uk/about-ucb-uk1

UCB Cares

Tel: +44 (0) 1753 777 100

Email: [email protected]

Inspire therapy is a small, fully implanted system that senses breathing patterns and delivers mild stimulation to maintain multilevel airway patency during sleep. Upper airway stimulation technology provides a first of its kind alternative for those suffering from obstructive sleep apnea who are unable to use or get consistent benefit from CPAP.

The system consists of a breathing sensor lead and stimulation lead, powered by a small battery. While the patient is sleeping, Inspire monitors each breath. Based on these unique breathing patterns, the system delivers mild stimulation to the hypoglossal nerve, keeping the tongue and other soft tissues out of the airway during sleep.

Inspire therapy is controlled using the small, handheld Inspire Sleep Remote. The patient uses the remote to turn the therapy on and off, adjust stimulation strength and pause during the night if needed.

Supporter

British Sleep Society Hands-On Meeting | 17 – 18 May 2018 | Dundee, Scotland, UK

A practical, clinically-focused conference aimed at multidisciplinary individuals with a professional interest in sleep medicine.

Workshop topics include: Sleep staging | Telemonitoring | Actigraphy | Paediatric sleep studies | Introduction to CBTi | Transition clinic case studies

Download the programme here

Download the flyer here

Programme overview

Keynote lecture by Prof Meir Kryger, Yale/US: The Mystery of Sleep. Download the latest agenda for more details

Sleep and the social impact of sleep associated symptoms have become more important with a demanding modern lifestyle. Recent years have seen a significant increase in patients reporting symptoms of hypersomnia and insomnia, or circadian rhythm disorders. The world-wide obesity epidemic has also led to a significant rise in the prevalence of sleep-disordered breathing, particularly in obstructive sleep apnoea. New insights into the complex interrelationship between parasomnias and neurodegenerative conditions emphasize the importance of sleep medicine to public health.

However, sleep disorders remain under-recognised by the medical community, which is largely due to the failure to question patients about their sleep quality and related symptoms and the difficulty in having sufficient capacity to assess the patient during sleep.

The 3rd Clinical Update Sleep™ will guide the delegates through the latest developments of sleep medicine, and review the evidence for the diagnosis and treatment of patients with sleep disorders, including obstructive sleep apnoea, hypersomnia, parasomnia and insomnia, as well as circadian rhythm disorders.

The conference is set up in a multi-disciplinary approach to highlight different aspects of the management of patients with sleep disorders. An update on recent clinical trials and hot topics concludes the day. A poster session will provide investigators the chance to present original data and network among their peer group.

The event is held in an open space environment to encourage interaction and exchange, interesting topics will be showcased throughout the day in a parallel programme, allowing to choose and pick the most interesting speakers as you go.

The programme will be printed in the conference proceedings and provided on admission.

6 CPD points have been awarded by the Royal College of Physicians.

Key topics covered include:

• Sleep apnoea and the cardiovascular system
• CPAP and non-CPAP therapy of sleep apnoea
• Clinical hypersomnias and Kleine-Levin Syndrome
• Narcolepsy and Cataplexy syndrome
• Insomnia Guidelines
• Update on clinical circadian rhythm disorders
• Clinical non-REM parasomnias
• REM-sleep behaviour disorder and neurodegenerative conditions
• Restless Legs Syndrome and Periodic Limb Movements
• Sleep-disordered breathing and comorbidities
• Sleep and Neurocognition
• Clinical Trials and Hot Topics

Download the final agenda >>

Book your place >>

The 3rd Clinical Update Sleep™: International Conference 2018 is endorsed by the European Respiratory Society

The Journal of Thoracic Disease is the exclusive publisher of the conference proceedings. Find out more here